Cofinimmo SA (LON:0J3X)
74.15
+0.60 (0.81%)
At close: Oct 24, 2025
Cofinimmo Revenue
Cofinimmo had revenue of 84.08M EUR in the quarter ending September 30, 2025, a decrease of -1.12%. This brings the company's revenue in the last twelve months to 389.40M, down -0.62% year-over-year. In the year 2024, Cofinimmo had annual revenue of 391.72M with 0.71% growth.
Revenue (ttm)
389.40M EUR
Revenue Growth
-0.62%
P/S Ratio
7.27
Revenue / Employee
2.60M EUR
Employees
150
Market Cap
2.47B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 391.72M | 2.75M | 0.71% |
| Dec 31, 2023 | 388.97M | 21.26M | 5.78% |
| Dec 31, 2022 | 367.71M | 24.59M | 7.17% |
| Dec 31, 2021 | 343.12M | 50.38M | 17.21% |
| Dec 31, 2020 | 292.73M | 7.36M | 2.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |